Have a personal or library account? Click to login

Clinicopathologic Profile and Outcome of Extranodal Diffuse Large B-Cell NHL: Egyptian National Cancer Institute Experience

Forum of Clinical Oncology
Volume 6 (2015): Issue 3 (September 2015)
By:
Open Access
|Dec 2015

References

  1. 1] Harris NL (2001) Mature B-cell neoplasms In: WHO Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues, Jaffe EJ, Harris NL, Stein H et al. (eds), Lyon, France, IARC Press, p 121- 126
    Search in Google Scholar
  2. [2] Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-2910.3322/canjclin.54.1.814974761
    Search in Google Scholar
  3. [3] Groves FD, Linet MS, Travis LB, et al (2000) Cancer surveillance series: Non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 92:1240-1251.10.1093/jnci/92.15.124010922409
    Search in Google Scholar
  4. [4] Mokhtar N, Gouda I, and Adel I (2007) Lymphoma in: Cancer Registry 2003-2004, p 36.
    Search in Google Scholar
  5. [5] Hans CP, Weisenburger DD, Greiner TC, et al. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood; 103:275-282.10.1182/blood-2003-05-154514504078
    Search in Google Scholar
  6. [6] Krol ADG, leCessie S, and Snijder S (2003) Primary extranodal non-Hodgkin’s lymphoma (NHL): The impact of alternative definitions tested in the Comprehensive Cancer Center West populationbased NHL registry. Ann Oncol; 14; 131-9.10.1093/annonc/mdg00412488305
    Search in Google Scholar
  7. [7] Lossos IS, Czerwinsli DK, Alizadeh AA et al. (2004) Prediction of survival in diffuse large B-cell lymphoma based on the expression of six genes. N Engl J Med; 350:1828-3710.1056/NEJMoa03252015115829
    Search in Google Scholar
  8. [8] Pileri SA, Dimhofer S, Went Ph, et al. (2002) Diffuse large B-cell lymphoma: One or more entities? Present controversies and possible tools for its subclassification. Histopathology; 41:482-509.10.1046/j.1365-2559.2002.01538.x12460202
    Search in Google Scholar
  9. [9] Rosenwald A, Wright G, Chan WC, et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med; 346:1937-1947.10.1056/NEJMoa01291412075054
    Search in Google Scholar
  10. [10] McClintock S, Perkins SL, Cleveland RP, et al. (2003) Immunohistochemical expression pattern of germinal center and activation B-cell markers correlates with prognosis in diffuse large B-cell lymphoma. Mod Pathol; 16:244.
    Search in Google Scholar
  11. [11] Colomo L, Lopez-Guillermo A, Perales M, et al. (2003) Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood; 101:78-84.10.1182/blood-2002-04-128612393466
    Search in Google Scholar
  12. [12] Linderoth J, Jerkeman M, Cavallin-Stahl E, Kvaloy S, Torlakovic E. (2003) Immunohistochemical expression of CD23 and CD40 may identify prognosticallyfavorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. Clin Cancer Res; 9:722-728.
    Search in Google Scholar
  13. [13] Barrans SL, Carter I, Owen RG, et al. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood; 99:1136-1143.10.1182/blood.V99.4.113611830458
    Search in Google Scholar
  14. [14] Lopez-Guillermo A, Colomo L, Jimenez M, et al. (2005) Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. Journal of Clinical Oncology, 23; 2797.10.1200/JCO.2005.07.15515728226
    Search in Google Scholar
  15. [15] Negri E, Little D, Boiocchi M, et al. (2004) B-cell non-Hodgkin’s lymphoma and hepatitis C virus infection: A systematic review. International Journal of Cancer; 111:1-8.10.1002/ijc.2020515185336
    Search in Google Scholar
  16. [16] Lal A, Bhurgri Y, Vaziri I, Rizvi NB, et al. (2008) Extranodal Non-Hodgkin’s Lymphomas - A retrospective review of clinicopathologic features and outcomes in comparison with nodal non- Hodgkin lymphomas. Asian Pacific Journal of Cancer Prevention; 9:453.
    Search in Google Scholar
DOI: https://doi.org/10.1515/fco-2015-0013 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 8 - 12
Submitted on: Mar 11, 2015
Accepted on: Jul 6, 2015
Published on: Dec 17, 2015
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Extranodal,
NHL,
clinicopathologic profile
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2015 Ola Khorshed, Amany Helal, Yasser A. Sallam, Asmaa Salama, Mohammad Amin, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 6 (2015): Issue 3 (September 2015)Next article